Get startedLog in
    Picture of Isofol Medical AB (publ) logo

    ISOFOL — Isofol Medical AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Isofol Announces New Preclinical Data Supporting Development Plan For Arfolitixorin

    Picture of Isofol Medical AB (publ) logoIsofol Medical AB (publ)
    16/07/2024 10:17
    July 16 (Reuters) - Isofol Medical AB (publ)
 ISOFOL.ST :
    * ANNOUNCES NEW PRECLINICAL DATA SUPPORTING THE PREVIOUSLY
COMMUNICATED CLINICAL DEVELOPMENT PLAN FOR ARFOLITIXORIN
    * STUDIES SHOW THAT INCREASED DOSES OF ARFOLITIXORIN IN
COMBINATION WITH 5-FU LEAD TO SIGNIFICANTLY HIGHER EFFICACY
    * STUDY RESULT INDICATES DIFFERENCES BETWEEN ARFOLITIXORIN
AND
LEUCOVORIN MAY BE FURTHER AMPLIFIED AT HIGHER DOSE LEVEL

Source text for Eikon:  ID:nMFN6t3L6w 
Further company coverage:  ISOFOL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

    Recent news on Isofol Medical AB (publ)

    See all news